BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23083570)

  • 1. Clinical results of DTI.
    Shapiro-Feinberg M; Weisenberg N; Zehavi T; Furman-Haran E; Grobgeld D; Nissan N; Degani H
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S151-2. PubMed ID: 23083570
    [No Abstract]   [Full Text] [Related]  

  • 2. The fibrotic focus in MR-mammography.
    Van Goethem M; Hufkens G; Verslegers I; Van Marck V; Biltjes I; Parizel PM
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S179-80. PubMed ID: 23083581
    [No Abstract]   [Full Text] [Related]  

  • 3. What is specific in hereditary breast cancer? High T2 signal intensity as a new semeiotic pattern?
    Trecate G; Agresti R; Suman L; Vergnaghi D; Valeri B; Marchesini M; Ferranti C; Ferraris C; Manoukian S; Scaperrotta G; ViganĂ² S; Panizza P
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S165-70. PubMed ID: 23083576
    [No Abstract]   [Full Text] [Related]  

  • 4. Advantages and drawbacks of breast DTI.
    Furman-Haran E; Eyal E; Shapiro-Feinberg M; Nissan N; Grobgeld D; Weisenberg N; Degani H
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S45-7. PubMed ID: 23083598
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical indications: what is the evidence?
    Lehman CD
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S82-4. PubMed ID: 23083615
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy--monitoring: clinical examination, ultrasound, mammography, MRI, elastography: only one, only few or all?
    Schulz-Wendtland R
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S147-8. PubMed ID: 23083568
    [No Abstract]   [Full Text] [Related]  

  • 7. What to do with B3 lesions at needle biopsy.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S90-2. PubMed ID: 23083618
    [No Abstract]   [Full Text] [Related]  

  • 8. Can we use MR-mammography to predict nodal status?
    Carbonaro LA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S17-8. PubMed ID: 23083577
    [No Abstract]   [Full Text] [Related]  

  • 9. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
    Granader EJ; Dwamena B; Carlos RC
    Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion weighted imaging: a long way to clinical routine.
    Woodhams R; Ozaki M; Hata H; Inoue Y
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S185-7. PubMed ID: 23083584
    [No Abstract]   [Full Text] [Related]  

  • 11. MRI in B3 lesions, low grade DCIS, high DCIS: is MR selecting the dangerous cases?
    Zuiani C; Londero V; Linda A; Girometti R; Bazzocchi M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S189-91. PubMed ID: 23083586
    [No Abstract]   [Full Text] [Related]  

  • 12. Diffusion weighted imaging (DWI) of the breast: ready for clinical practice?
    Lehman CD
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S80-1. PubMed ID: 23083614
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated quantitative DCE-MRI and DW-MRI to characterize breast lesions.
    Jena A; Taneja S; Mehta SB
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S64-5. PubMed ID: 23083607
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffusion-weighted MRI as an adjunct to mammography in women under 50 years of age: an initial study.
    Kazama T; Kuroki Y; Kikuchi M; Sato Y; Nagashima T; Miyazawa Y; Sakakibara M; Kaneoya K; Makimoto Y; Hashimoto H; Motoori K; Takano H
    J Magn Reson Imaging; 2012 Jul; 36(1):139-44. PubMed ID: 22359367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACR Appropriateness Criteria on palpable breast masses.
    Parikh JR
    J Am Coll Radiol; 2007 May; 4(5):285-8. PubMed ID: 17467609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can breast MRI facilitate decision-making in equivocal mammography and ultrasonography findings?
    Ozcan UA; Ocak F; Altun E
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S112-3. PubMed ID: 23083552
    [No Abstract]   [Full Text] [Related]  

  • 17. JOURNAL CLUB: Is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results.
    Arazi-Kleinman T; Skair-Levy M; Slonimsky E; Maly B; Uziely B; Libson E; Sella T
    AJR Am J Roentgenol; 2013 Oct; 201(4):919-27. PubMed ID: 24059385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of current evidence-based clinical applications for breast magnetic resonance imaging.
    DeMartini W; Lehman C
    Top Magn Reson Imaging; 2008 Jun; 19(3):143-50. PubMed ID: 18941394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
    J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.